We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.29%
This Fund
S&P 500
This Quarter Est. Return
-1.04%
1 Year Est. Return
+106.29%
3 Year Est. Return
+266.67%
5 Year Est. Return
+310.43%
10 Year Est. Return
+1,579.99%
AUM
$4.3B
AUM Growth
+$50.2M
Cap. Flow
-$180M
Cap. Flow %
-4.19%
Top 10 Hldgs %
8.21%
Holding
2,738
New
923
Increased
478
Reduced
355
Closed
498

Top Buys

Rank Stock Value
1
MBB icon
iShares MBS ETF
MBB
+$20.1M
2
AXAC
AXIOS Sustainable Growth Acquisition Corporation
AXAC
+$11M
3
CNGL
Canna-Global Acquisition Corp. Class A Common Stock
CNGL
+$9.93M
4
SAGA
Sagaliam Acquisition Corp. Class A Common Stock
SAGA
+$9.76M
5
NUBIU
Nubia Brand International Corp. Unit
NUBIU
+$9.67M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$103M
2
PFE icon
Pfizer
PFE
+$63M
3
CRM icon
Salesforce
CRM
+$40.7M
4
XLNX
Xilinx Inc
XLNX
+$32.9M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$26M

Sector Composition

Rank Sector Weight
1 Financials 13.47%
2 Healthcare 7.77%
3 Technology 7.7%
4 Consumer Discretionary 4.85%
5 Energy 4.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HARP
2126
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$56K ﹤0.01%
1,120
– –
FXCOR
2127
DELISTED
Financial Strategies Acquisition Corp. Rights
FXCOR
$56K ﹤0.01%
+350,000
New +$69.6K
AMPY icon
2128
Amplify Energy
AMPY
$168M
$55K ﹤0.01%
+10,074
New +$46.5K
SHCR
2129
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$55K ﹤0.01%
+22,218
New +$73K
ARIZR
2130
DELISTED
Arisz Acquisition Corp. Right
ARIZR
$53K ﹤0.01%
330,000
– –
DBVT
2131
DBV Technologies
DBVT
$864M
$52K ﹤0.01%
3,286
– –
DMAC icon
2132
DiaMedica Therapeutics
DMAC
$365M
$52K ﹤0.01%
20,603
– –
HTCR icon
2133
HeartCore Enterprises
HTCR
$3.7M
$52K ﹤0.01%
+900
New +$49.6K
LGHLW
2134
DELISTED
Lion Group Holding Ltd. Warrant
LGHLW
$52K ﹤0.01%
32,895
-863
-3% -$91
OKUR
2135
OnKure Therapeutics
OKUR
$168M
$52K ﹤0.01%
1,765
– –
GBRGR
2136
DELISTED
Goldenbridge Acquisition Limited Right
GBRGR
$52K ﹤0.01%
310,317
– –
CRBP icon
2137
Corbus Pharmaceuticals
CRBP
$180M
$51K ﹤0.01%
3,180
– –
OTIC
2138
DELISTED
Otonomy, Inc.
OTIC
$51K ﹤0.01%
21,048
– –
GSIT icon
2139
GSI Technology
GSIT
$254M
$50K ﹤0.01%
+13,000
New +$55.8K
ATAKR
2140
DELISTED
Aurora Technology Acquisition Corp. Rights
ATAKR
$50K ﹤0.01%
+335,000
New +$51.4K
MILE
2141
DELISTED
Metromile, Inc. Common Stock
MILE
$50K ﹤0.01%
37,500
– –
MBIO icon
2142
Mustang Bio
MBIO
$4.36M
$49K ﹤0.01%
64
– –
WINVR
2143
DELISTED
WinVest Acquisition Corp. Right
WINVR
$49K ﹤0.01%
590,000
-310,000
-34% -$50.5K
AIBBR
2144
DELISTED
AIB Acquisition Corp Right
AIBBR
$49K ﹤0.01%
+350,000
New +$58.6K
ICCM icon
2145
IceCure Medical
ICCM
$10.6M
$48K ﹤0.01%
667
– –
NRSN icon
2146
NeuroSense Therapeutics
NRSN
$18.2M
$48K ﹤0.01%
+12,170
New +$29K
BBIG
2147
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$46K ﹤0.01%
1,051
-865
-45% -$34.5K
ASMB icon
2148
Assembly Biosciences
ASMB
$524M
$44K ﹤0.01%
1,784
– –
CYPH
2149
Cypherpunk Technologies Inc
CYPH
$71.7M
$43K ﹤0.01%
+2,477
New +$53K
AGTC
2150
DELISTED
Applied Genetic Technologies Corporation
AGTC
$42K ﹤0.01%
38,953
– –
84 85
86
87 88

Similar funds

MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

Boothbay Fund Management's Q1 2022 Portfolio in Review

As of Q1 2022, Boothbay Fund Management held 2,738 positions worth $4.3B, up 1.2% from $4.25B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

Boothbay Fund Management withdrew a net $180M in Q1 2022, closing 498 positions and reducing 355 holdings. Its most notable exit was Xilinx Inc, an estimated $32.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Boothbay Fund Management opened a new position in AXIOS Sustainable Growth Acquisition Corporation worth $11M.

  • Boothbay Fund Management's largest Q1 2022 buy was AXIOS Sustainable Growth Acquisition Corporation: 1,100,000 shares worth $11M.
  • Boothbay Fund Management added most to iShares MBS ETF in Q1 2022, an estimated $20.1M increase.
  • Boothbay Fund Management's biggest Q1 2022 reduction was Amazon, cutting an estimated $103M.
  • Boothbay Fund Management fully exited Xilinx Inc in Q1 2022, selling an estimated $32.9M.
  • Boothbay Fund Management's ten largest holdings make up 8.2% of its $4.3B portfolio in Q1 2022.
  • Boothbay Fund Management opened 923 new positions and closed 498 in Q1 2022.
  • Boothbay Fund Management's portfolio value rose 1.2% quarter-over-quarter to $4.3B.

Based on Boothbay Fund Management's 13F filing for Q1 2022, filed 16 May 2022.